Multifunctional G-Quadruplex Aptamers and Their Application to Protein Detection

被引:139
作者
Li, Tao [1 ,2 ]
Shi, Lili [3 ]
Wang, Erkang [1 ,2 ]
Dong, Shaojun [1 ,2 ]
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
[3] NE Normal Univ, Dept Chem, Inst Funct Mat Chem, Changchun 130024, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
DNA; DNAzyme; G-quadruplex; hemin; multifunctional aptamers; proteins; TETRAD-FORMING OLIGONUCLEOTIDES; INTRAMOLECULAR DNA QUADRUPLEXES; G-RICH OLIGONUCLEOTIDES; CATIONIC PORPHYRINS; PEROXIDASE-ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; HIV-1; INTEGRASE; HUMAN THROMBIN; IN-VITRO; BINDING;
D O I
10.1002/chem.200801282
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Two significant G-quadruplex aptamers named AGRO100 and T30695 are identified as multi functional aptamers that can bind the protein ligands nucleolin or HIV-1 integrase and hemin. Besides their strong binding to target proteins, both AGRO100 and T30695 exhibit high hemin-binding affinities comparable to that of the known aptamer (termed PS2M) selected by the in vitro evolution process. Most importantly, their corresponding hemin-DNA complexes reveal excellent peroxidase-like activities. higher than that of the reported hemin-PS2M DNAzyme. This enables these multifunctional aptamers to be applied to the sensitive detection of proteins. which is demonstrated by applying AGRO100 to the chemiluminescence detection of nucleolin expressed at the surface of HeLa cells. Based on the specific AGRO100-nucleolin interaction, the surface-expressed nucleolin of HeLa cells is labeled in situ with the hemin-AGRO100 DNAzyme, and then determined in the luminol-H2O2 system. Through this approach, the sensitive detection of total nucleolin expressed at the Surface of about 6000 HeLa cells is accomplished. Our results suggest that exploiting new functions of existing aptamers will help to extend their potential applications in the biochemical field.
引用
收藏
页码:1036 / 1042
页数:7
相关论文
共 42 条
[1]   Porphyrin binding to quadruplexed T4G4 [J].
Anantha, NV ;
Azam, M ;
Sheardy, RD .
BIOCHEMISTRY, 1998, 37 (09) :2709-2714
[2]   DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity [J].
Andreola, ML ;
Pileur, F ;
Calmels, C ;
Ventura, M ;
Tarrago-Litvak, L ;
Toulmé, JJ ;
Litvak, S .
BIOCHEMISTRY, 2001, 40 (34) :10087-10094
[3]   Antiproliferative activity of G-rich oligonucleotides correlates with protein binding [J].
Bates, PJ ;
Kahlon, JB ;
Thomas, SD ;
Trent, JO ;
Miller, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26369-26377
[4]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[5]   Hemin-stimulated docking of cytochrome c to a hemin-DNA aptamer complex [J].
Chinnapen, DJF ;
Sen, D .
BIOCHEMISTRY, 2002, 41 (16) :5202-5212
[6]   DNA aptamers as potential anti-HIV agents [J].
Chou, SH ;
Chin, KH ;
Wang, AHJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (05) :231-234
[7]   Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications [J].
Dapic, V ;
Bates, PJ ;
Trent, JO ;
Rodger, A ;
Thomas, SD ;
Miller, DM .
BIOCHEMISTRY, 2002, 41 (11) :3676-3685
[8]   DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents [J].
de Soultrait, VR ;
Lozach, PY ;
Altmeyer, R ;
Tarrago-Litvak, L ;
Litvak, S ;
Andréola, ML .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 324 (02) :195-203
[9]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822
[10]   AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin [J].
Girvan, Allicia C. ;
Teng, Yun ;
Casson, Lavona K. ;
Thomas, Shelia D. ;
Juliger, Simone ;
Ball, Mark W. ;
Klein, Jon B. ;
Pierce, William M., Jr. ;
Barve, Shirish S. ;
Bates, Paula J. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (07) :1790-1799